AxoGen: Rev generating; addressing peripheral nerve repair w portfolio of regenerative medicine products in US, Canada et al. Products incl. Avance Nerve Graft: off-the-shelf commercially avail processed human nerve allograft bridging severed nerves w/o comorbidities assoc w addl surgical site. 3Q18 revenue ($22.7M), up 41% vs $16M (3Q17).
Healthcare/Medical Devices & Instruments
Based in...
US - South Atlantic
Clinical Stage
Marketed, Phase III
Disease Space
Central Nervous System, Pain
Biotechnology, Medical Device
Public, USA
Market Cap
100MM - 500MM
13631 Progress Blvd
Suite 400
Alachua, FL 32615
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Axogen, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
ArrowMark Colorado Holdings LLC 16.14 6,329,173 71.55 13F 2020-03-31
Consonance Capital Management LP 9.10 3,566,054 40.31 13F 2020-03-31
The Vanguard Group, Inc. 6.24 2,444,531 27.64 Funds 2020-05-31
Essex Woodlands Management, Inc. 6.20 2,429,999 27.47 13F 2020-03-31
Vanguard Group, Inc. (Subfiler) 4.55 1,783,783 20.17 13F 2020-03-31
Wellington Management Co. LLP 3.52 1,378,442 15.58 Funds 2020-03-31
BlackRock Fund Advisors 3.32 1,301,293 14.71 13F 2020-03-31
Managed Account Advisors LLC 2.80 1,096,446 12.40 13F 2020-03-31
Baillie Gifford & Co. 2.66 1,042,530 11.79 13F 2020-03-31
William Blair Investment Management LLC 2.65 1,037,800 11.73 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.